Core Viewpoint - The company announced that its Executive Director and Chairman, Dr. Pan Honghui, purchased 100,000 shares at an average price of approximately HKD 6.83 per share, totaling around HKD 683,000, indicating confidence in the company's growth prospects [1] Group 1: Share Purchase Details - Dr. Pan acquired 100,000 ordinary shares in the open market at an average price of approximately HKD 6.83 per share [1] - The total cost of the share purchase was approximately HKD 683,000 [1] - Following the purchase, Dr. Pan holds a total of 17,627,696 shares, representing 16.44% of the company's issued share capital as of the announcement date [1] Group 2: Future Intentions - Dr. Pan expressed confidence in the overall development prospects and potential growth of the group [1] - He does not rule out the possibility of further increasing his shareholding in the company at an appropriate time, subject to applicable laws and regulations [1]
圣诺医药-B获主席潘洪辉增持10万股